sygnaturediscovery.com

Website review sygnaturediscovery.com

Sygnature Discovery - Leading Contract Research Organisation

 Generated on April 06 2026 22:57 PM

Old data? UPDATE !

The score is 63/100

SEO Content

Title

Sygnature Discovery - Leading Contract Research Organisation

Length : 60

Perfect, your title contains between 10 and 70 characters.

Description

Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).

Length : 133

Great, your meta description contains between 70 and 160 characters.

Keywords

Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
locale en_US
type website
title Sygnature Discovery - Leading Contract Research Organisation
description Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
url https://www.sygnaturediscovery.com/
site_name Sygnature
image https://www.sygnaturediscovery.com/wp-content/uploads/2026/02/sygnature-hit-to-lead-team-collaboration-scaled.webp
image:width 2560
image:height 1707
image:type image/webp

Headings

H1 H2 H3 H4 H5 H6
1 25 28 137 8 0
  • [H1] Achieving exceptional scientific outcomesthrough connected drug discovery.
  • [H2] World-leading drug discovery solutions, accelerating your compound to the clinic.
  • [H2] We offer deep expertise across the full range of drug discovery solutions.
  • [H2] We deliver world-class scientific expertise and flexible services across every discipline in preclinical discovery.
  • [H2] Integrated Drug Discovery
  • [H2] Computer Aided Drug Design
  • [H2] Protein & Structure
  • [H2] Bioscience
  • [H2] Chemistry
  • [H2] Drug Metabolism and Pharmacokinetics (DMPK)
  • [H2] in vivo Pharmacology
  • [H2] Form and Formulation
  • [H2] We offer specialist expertise across a range of modalities, target classes and therapeutic areas.
  • [H2] Modalities
  • [H2] Target Classes
  • [H2] Therapeutic Areas
  • [H2] World-leading drug discovery
  • [H2] At Sygnature Discovery, we create exceptional scientific outcomes
  • [H2] Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America
  • [H2] Impact that lasts
  • [H2] Our track record
  • [H2] Trusted by customers worldwide
  • [H2] Interested in joining our team?
  • [H2] News & Resources
  • [H2] Ready to start a conversation?
  • [H2] You're in the right place!
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources Overview
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] From Lead to Pre-Candidate Nomination in 18 Months
  • [H3] Sitryx: Empowering New Ideas
  • [H3] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H3] Corcept Therapeutics: Integrated Drug Discovery Collaboration
  • [H3] CellCentric Lead Optimisation Campaign – CCS1477
  • [H3] Fragment-based hit discovery for the epigenetic target, BRD3
  • [H3] Hit Identification to 3 Compounds in the Clinic and 6 Development Candidates
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Computer Aided Drug Design
  • [H4] Bioinformatics
  • [H4] Target Analysis
  • [H4] Virtual Screening
  • [H4] Structure Based Drug Design
  • [H4] Generative AI and Machine Learning
  • [H4] Ligand Based Drug Design
  • [H4] Library Design
  • [H4] ADMET Predictions
  • [H4] Informatics
  • [H4] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H4] Protein Science and Structural Biology
  • [H4] Protein Expression and Purification
  • [H4] Membrane Proteins
  • [H4] Antibodies and Biotherapeutics
  • [H4] Structural Biology
  • [H4] X-Ray Crystallography
  • [H4] cryo-EM
  • [H4] Macromolecular NMR
  • [H4] Protein Characterization
  • [H4] Protein Mass Spectrometry
  • [H4] FIDA
  • [H4] A Comparison of the Structural Techniques used at Sygnature Discovery: X-ray Crystallography, NMR and Cryo-EM
  • [H4] Bioscience
  • [H4] Cell Line Generation
  • [H4] Assay Development
  • [H4] Electrophysiology
  • [H4] High Throughput Screening
  • [H4] Cell Based Assays
  • [H4] Biochemical Assays
  • [H4] Biophysical Assays
  • [H4] Primary Cells and Tissues
  • [H4] Integrating Hit Finding and Direct-to-Biology to Shorten Time to Development Candidate
  • [H4] Chemistry
  • [H4] Medicinal Chemistry
  • [H4] Synthetic Chemistry
  • [H4] Process & Scale-up Chemistry
  • [H4] NMR-Spectroscopy
  • [H4] Separation Sciences
  • [H4] High Throughput Chemistry
  • [H4] Why Early Process Chemistry Matters?
  • [H4] Drug Metabolism and Pharmacokinetics
  • [H4] Physicochemical Profiling
  • [H4] Chemical & Metabolic Stability
  • [H4] Permeability
  • [H4] Tissue Binding
  • [H4] Drug-Drug Interactions
  • [H4] Biotransformation
  • [H4] Analytical Method Development & Bioanalysis
  • [H4] in vivo Pharmacokinetic & Pharmacodynamic Studies
  • [H4] PK & PK/PD Modelling and Simulation
  • [H4] DMPK Consultancy
  • [H4] Dedicated DMPK for Bifunctional Degraders: A Flexible Approach for Flexible Molecules
  • [H4] in vivo Pharmacology
  • [H4] CNS/Pain Models
  • [H4] Metabolic Disease Models
  • [H4] Inflammation & Immunology Models
  • [H4] Oncology Models
  • [H4] Non-Regulatory Toxicology
  • [H4] in vivo Pharmacokinetics
  • [H4] ex vivo Tissue Analysis
  • [H4] Evaluation of Two Novel Compounds Compared to Methadone on Morphine Withdrawal in a Rat Model of Physical dependence
  • [H4] Form & Formulation
  • [H4] Early Clinical Formulation
  • [H4] Solid Form Analysis
  • [H4] Salt and Co-Crystal Screening
  • [H4] Polymorph Screening
  • [H4] Pre-Clinical Formulation
  • [H4] Assessing Lypoprotectant Effect on Particle Size of Liposomal Systems
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Ion Channels
  • [H4] GABAA Receptors
  • [H4] NMDA Receptors
  • [H4] Glycine Receptors
  • [H4] Nicotinic Receptors
  • [H4] TRP Channels
  • [H4] Sodium Channels
  • [H4] Calcium Channels
  • [H4] Potassium Channels
  • [H4] Chloride Channels
  • [H4] TMEM175
  • [H4] Delivering Custom Cell-Based Tools for Drug Discovery
  • [H4] Sygnature Discovery Successfully Provides Clinical Candidate to Corcept Therapeutics
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] Blog
  • [H4] Webinars & Podcasts
  • [H4] Posters
  • [H4] Journal Papers
  • [H4] Technical Notes
  • [H4] Case Studies
  • [H4] eBooks
  • [H4] Protocols
  • [H4] News
  • [H4] Events
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] UK (Nottingham)
  • [H5] Our Office Locations
  • [H5] Drug Discovery
  • [H5] modalities
  • [H5] Target Classes
  • [H5] Scientific solutions
  • [H5] Therapeutic Areas
  • [H5] Website
  • [H5] Resource Hub

Images

We found 77 images on this web page.

38 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.

Text/HTML Ratio

Ratio : 26%

Ideal! This page's ratio of text to HTML code is between 25 and 70 percent.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

We have detected underscores in your URLs. You should rather use hyphens to optimize your SEO.

In-page links

We found a total of 70 links including 4 link(s) to files

Anchor Type Juice
Explore the STORM Therapeutics case study Internal Passing Juice
Contact Internal Passing Juice
Contact us Internal Passing Juice
Get in touch Internal Passing Juice
What we do Internal Passing Juice
Learn more about Drug Discovery Internal Passing Juice
Learn more about Scientific Solutions Internal Passing Juice
Explore CADD Internal Passing Juice
Explore Protein and Structure Internal Passing Juice
Explore Bioscience Internal Passing Juice
Explore Chemistry Internal Passing Juice
Explore DMPK Internal Passing Juice
Explore in vivo Pharmacology Internal Passing Juice
Explore Form and Formulation Internal Passing Juice
Discover our Modalities Internal Passing Juice
Learn more about Target Classes Internal Passing Juice
Explore our Therapeutic Areas Internal Passing Juice
At Sygnature Discovery, we create exceptional scientific outcomes Internal Passing Juice
Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America Internal Passing Juice
Impact that lasts Internal Passing Juice
Learn more Internal Passing Juice
Read the case study Internal Passing Juice
Read the case study Internal Passing Juice
Read the case study Internal Passing Juice
Read the case study Internal Passing Juice
Read the case study Internal Passing Juice
Read the case study Internal Passing Juice
View our Careers Page Internal Passing Juice
Bringing Connected Drug Discovery Together Under One Name Internal Passing Juice
Dr Simon Hirst awarded prestigious honorary Doctorate from the University of Nottingham Internal Passing Juice
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment Internal Passing Juice
Sygnature Discovery boosts growth of its in vivo Pharmacology business with appointment of new Vice President Internal Passing Juice
Sygnature Discovery Appoints New Chief Commercial Officer to Drive Next Phase of Business Growth Internal Passing Juice
Sygnature Discovery appoints Rick Davies to spearhead growth as Director of its UK Protein Sciences and Structural Biology business (formerly, Peak Proteins) Internal Passing Juice
View all locations Internal Passing Juice
Target Identification & Validation Internal Passing Juice
Hit Identification Internal Passing Juice
Hit-to-Lead Internal Passing Juice
Lead Optimization Internal Passing Juice
Small Molecules Internal Passing Juice
Peptides Internal Passing Juice
Targeted Protein Degradation Internal Passing Juice
ADCs Internal Passing Juice
Biologics Internal Passing Juice
Ion channels Internal Passing Juice
GPCRs Internal Passing Juice
Transporters Internal Passing Juice
Oncology Internal Passing Juice
Inflammation and Immunology Internal Passing Juice
Neuroscience Internal Passing Juice
Metabolic Diseases Internal Passing Juice
Meet our Team Internal Passing Juice
Working with us Internal Passing Juice
Environmental, social, governance Internal Passing Juice
Blog Internal Passing Juice
Webinars & Podcasts Internal Passing Juice
Posters Internal Passing Juice
Journal Papers Internal Passing Juice
Technical Notes Internal Passing Juice
eBooks Internal Passing Juice
Protocols Internal Passing Juice
Case Studies Internal Passing Juice
News Internal Passing Juice
Events Internal Passing Juice
Privacy Policy Internal Passing Juice
Cookie Policy Internal Passing Juice
Website terms of use Internal Passing Juice
Modern Slavery Statement Internal Passing Juice
Supplier Code of Conduct Internal Passing Juice
Website Design Agency External Passing Juice

SEO Keywords

Keywords Cloud

expertise solutions target integrated sygnature chemistry discovery drug from design

Keywords Consistency

Keyword Content Title Keywords Description Headings
discovery 91
drug 68
sygnature 33
integrated 26
expertise 25

Usability

Url

Domain : sygnaturediscovery.com

Length : 22

Favicon

Great, your website has a favicon.

Printability

Great. We have found a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Too bad, your website has too many CSS files (more than 4).
Too bad, your website has too many JS files (more than 6).
Perfect, your website takes advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://www.sygnaturediscovery.com/sitemap_index.xml

Robots.txt

https://sygnaturediscovery.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Missing

We didn't detect an analytics tool installed on this website.

Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.

PageSpeed Insights

Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.